Home › Degenerative Nerve Diseases › Florida › Tampa
Degenerative Nerve Diseases clinical trials in Tampa, FL
5 studies for Degenerative Nerve Diseases are looking for participants at sites in and around Tampa (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
RecruitingPhase 2
- Clinical Site, Tampa
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
RecruitingPhase 2
- Axiom Brain Health LLC, Tampa
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
RecruitingPhase 2
- Vima Site #062, Tampa
Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study
RecruitingObservational studyHealthy volunteers welcome
- USF Ataxia Research Center, Tampa
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
RecruitingObservational studyHealthy volunteers welcome
- University of South Florida, Tampa
About Degenerative Nerve Diseases
Neurodegenerative (degenerative nerve) diseases are disorders that destroy motor neurons. Parkinson's is an examples. See a list of all the diseases.
More about Degenerative Nerve Diseases on MedlinePlus
Degenerative Nerve Diseases trials in other cities
- Philadelphia, PA6 studies
- Boston, MA5 studies
- Orlando, FL5 studies
- San Diego, CA4 studies
- Scottsdale, AZ4 studies
- Atlanta, GA4 studies
- San Francisco, CA3 studies
- Farmington Hills, MI3 studies
- Miami, FL3 studies
- Gainesville, FL3 studies
- West Palm Beach, FL3 studies
- Denver, CO3 studies
Other studies in Tampa
- Non-Small Cell Lung Cancer51 studies
- Breast Cancer43 studies
- Cancer (all types)39 studies
- Colorectal Cancer33 studies
- Metastatic Cancer29 studies
- Lung Cancer29 studies
- Acute Myeloid Leukemia29 studies
- Pancreatic Cancer26 studies
- Ovarian Cancer21 studies
- Myelodysplastic Syndromes19 studies
- Melanoma19 studies
- Heart Failure18 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.